Intended for healthcare professionals

Letters Email reminders and

Investigator contact details should continue to be available after completion of clinical trials

BMJ 2014; 349 doi: (Published 04 November 2014) Cite this as: BMJ 2014;349:g6640
  1. Stephen O’Neill, clinical research fellow1,
  2. Stephen J Wigmore, professor of transplantation surgery1,
  3. J Edward Fitzgerald, specialty registrar in surgery2,
  4. Aneel Bhangu, clinical lecturer in surgery3,
  5. Ewen M Harrison, senior lecturer in general surgery1
  1. 1Clinical Surgery, University of Edinburgh, Royal Infirmary of Edinburgh, Edinburgh EH16 4SA, UK
  2. 2Department of General Surgery, Barnet and Chase Farm Hospitals NHS Trust, Barnet, UK
  3. 3College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK
  1. ewen.harrison{at}

Timely dissemination of research findings is needed for research results to be successfully translated into practice.1 The Food and Drug Administration Amendments Act requires trials that are subject to mandatory reporting to post results within 12 months of study completion on Despite this initiative, less than a quarter of trial investigators comply.3

Maruani and colleagues report that email reminders of the legal requirement to post results significantly improved reporting at six months.4 …

View Full Text

Log in

Log in through your institution


* For online subscription